FEBRUARY 2023LIFE SCIENCES REVIEW5CONTENTSCXO INSIGHTSTHERAPEUTICS COMPANIES IN CANADA - 2023TOP 10FEATURED COMPANIESSEAFORD PHARMACEUTICALSTamara Seales,President35CYTOPHAGE TECHNOLOGIESDr. Steven Theriault,CEO & CSO27Three C's to Enable Continuous Development and Manufacturing for Small Molecule Active Pharmaceutical IngredientNick Thomson,Senior Director, Chemical Research and Development,Pfizer IncWorldwide Patients' Access to Life-Changing TherapiesKinga Bercsenyi,PhD, European Lead for Precision Medicine & Biomarker Solutions, Cerba Research28From ideation to portfolio program: Innovation vs validation in early drug discoveryCarlos Pedraza,Ph.D., Director of CNS Biology, Alkermes34Developing patient-centric precision oncology therapies: Begin with the end in mindSanjay Konagurthu,PhD, Senior Director, science and innovation, pharma services,Thermo Fisher Scientific32Analytics as a competitive advantage takes 3 things ­ access, cleanliness, and actionMatt Southwick,Executive Director Clinical Systems and Analytical Reporting,Amgen26Growing demand for More Specialized ServicesSpecialized Services: A New Paradigm in TherapeuticsBrian Fry,Director, Global Cell Therapy,Charles River Laboratories23How Technology Enhances the Effectiveness of Compliance ProgramsPatrik Florencio,SVP and Chief Compliance & Risk Officer, Amicus Therapeutics andMichael Schneider,Executive Director, Global ERM and Compliance Auditing,Amicus Therapeutics21IN MY OPINION0830RAKOVINA THERAPEUTICSJeffrey Bacha,Executive ChairmanDavid Hyman, CFOMads Daugaard, President & CSO22DEFENCE THERAPEUTICSDr. Moutih Rafei,VP
< Page 4 | Page 6 >